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In this study, we investigated the effects of co-administration of taurine and caffeine on 
thermally induced pain in sciatic nerve ligated rats as well as the roles of autonomic receptors. 
Rats were rendered neuropathic by unilateral sciatic nerve ligation. The anti-hyperalgesic 
effect of combined systemic (i.p.) administration of taurine and caffeine were assessed using 
tail flick tests and hot plate test for two weeks. To determine the involvement of autonomic 
nervous system, the study examined how administration of cholinergic (atropine and 
hexamethonium) and adrenergic (prazosin and propranolol) receptor blockers altered the 
combined effect of taurine and caffeine. Likewise, the serum level of oxidative stress marker 
malondialdehyde (MDA) was evaluated. The results showed that co-administration of taurine 
and caffeine attenuated thermal hyperalgesia in sciatic nerve ligated rats as shown by 
significant (p<0.05) increase in tail and paw withdrawal latencies in the treated groups 
compared to the ligated control group  after two weeks of administration. The anti nociceptive 
effects were reversed by pre-treatment with cholinergic blockers especially atropine while the 
adrenergic blockers spared the effects of taurine and caffeine. Also, the increase in tissue level 
of MDA induced by sciatic nerve ligation was significantly attenuated by combined 
administration of high dose of taurine and caffeine. It can be concluded that co-administration 
of taurine and caffeine attenuates thermal hyperalgesia in sciatic nerve-ligated rats (a model of 
neuropathic pain) and this effect involves cholinergic system. The findings suggest that co-




Neuropathic pain has been defined as pain caused by a 
lesion of the peripheral or central nervous system (or 
both), manifesting with sensory symptoms and signs 
(positive and negative sensory phenomena (Backonja, 
2003). Neuropathic pain is often associated with the 
appearance of abnormal sensory signs, such as 
allodynia (pain as a result of a stimulus which does not 
normally provoke pain) or hyperalgesia (an increased 
response to a stimulus which is normally painful) and 
often reported as having a lancinating or continuous 
burning character (Bridges et al., 2001). This form of 
pain requires more research and application of novel 
therapeutic drugs (Shmader, 2002). Clinically, tricyclic 
anti‐depressants and some anticonvulsants such as 
gabapentin have been employed in the management of 
neuropathic pain (Sindrup and Jensen, 2002). 
Taurine (2-aminoethanesulfonicacid) is an organic 
osmolyte (Terada et al., 2011) that is not incorporated 
into proteins. In the central nervous system, taurine has 
been implicated in cell volume regulation, 
neuroprotection and inhibitory neurotransmission 
(Gupta, 2006). Taurine is an important trophic factor in 
the development of the central nervous system (CNS) 
(Menzie, 2012). Antinocicepive effects of taurine in 
acute and inflammatory pain models have been 
documented (Silva et al., 1993; Serrano et al.,1994)
 
and 
its depletion has also been implicated in the 
development of neuropathic pain (Hansen, 2001). Also, 
Li et al., (2005) showed that  dietary supplementation 
with taurine suppressed hyperalgesia in streptozotocin 
(STZ)-induced diabetic rats, likewise taurine  induced 
attenuation of autotomic behaviour  in genetically 
© Copyright 2015 African Association of Physiological Sciences -ISSN: 2315-9987; e-ISSN: 2449-108X All rights reserved 
 
*Address for correspondence: 
Email: deleyele@yahoo.com or 
owoyele@unilorin.edu.ng 
 
Effects of taurine and caffeine on neuropathic pain 




selected Sabra strain rats has been reported (Belfer et 
al.,1998). 
Caffeine is widely consumed for its central nervous 
system (CNS) stimulant effects which include alertness 
and decreased fatigue. It is present in a variety of 
beverages (coffee, tea, energy drinks) and some foods 
(chocolate, desserts); it is also available as a drug 
where it is used as a stimulant, or is added to analgesics 
in over the-counter formulations (Fredholm et al., 
1999). Pharmacological actions of caffeine are related 
to its ability to block adenosine A1, A2A and A2B 
receptors (Fredholm et al., 1999). Caffeine can also 
inhibit phosphodiesterase, promote Ca
2+
 release and 
block GABAA receptors, but very high concentrations 
are required to elicit these effects (Fredholm et al., 
1999). Caffeine exhibits adjuvant properties when 
added to analgesic drugs by increasing the analgesic 
effect of the drug (Sawynok, 2011) . Owoyele et al. 
(2004), demonstrated that caffeine also exhibited anti-
nociceptive effect at 2.5mg/kg, 5mg/kg and 10mg/kg. 
While the only report on direct effect of caffeine on 
neuropathic pain was that of Wu et al. ( 2006) which 
stated that acute but not long term, caffeine intake 
reduced neuropathic pain state in nerve- injured rat. 
Caffeine has been shown to act as adjuvant to 
acetaminophen when administered together and 
according to Sawynok, (2011) it has been co 
administered with several analgesic agents in order to 
test whether it would enhance the resulting analgesic 
effects. Despite the number of studies on the effects of 
taurine or caffeine alone on pain related behaviour in 
chronic, inflammatory and neuropathic pain models, as 
far as we know, there is no single report on the effect of 
co-administration of taurine and caffeine on 
neuropathic pain. Therefore we hypothesised that co-
administration of taurine and caffeine could attenuate 
thermal hyperalgesia in chronic constriction injury 
model of neuropathic pain. This study was also aimed 
at investigating the possible involvement of autonomic 
receptor mechanism in the effects of taurine and its 
combination with caffeine. 
 
MATERIALS AND METHODS 
 
Drugs and reagents 
Taurine and caffeine;  MDA kits, hexamethonium and 
atropine were products of Sigma Chemical Co. (St. 
Louis MO, U.S.A) while propranolol and prazosin were 
products of Namco Chemicals, Amritsr, India. Normal 
saline and ketamine were purchased from Momrota 




A total of sixty six age matched male Wistar rats 
(Rattus norvegicus) weighing about 130±12.5g were 
employed in the present study.  They were placed under 
standard laboratory condition, maintained on a normal 
light-dark cycle in cages at the animal holding of our 
faculty. They were fed on standard chow diet and water 
ad libitum and were acclimatized to laboratory 
conditions for two weeks before the commencement of 
experiments. The animals were treated in accordance 
with the ethical guidelines of the university and the 
guidelines agreed with the internationally accepted 
principles for animal handling and care. 
 
Experimental protocol 
Animals were randomly divided into two study groups 
(1 and 2 respectively). There were 8 sub-groups (A-H) 
in study group 1 and 4 sub- groups (I-L) in study group 
2. Animals in the study group 1 were used to 
investigate the effect of combined systemic 
administration of taurine and caffeine on thermal 
hyperalgesia in sciatic nerve ligated rats while those in 
study group 2 were used to investigate the possible 
involvements of autonomic receptors in the combined 
effects of taurine and caffeine. The details of the 
groupings are as follows: 
Group A (control): Rats were not subjected to any 
surgical procedure or treatment and were kept for 14 
days. Animals in this group received normal saline 
(2ml/kg, i.p).The behavioural tests were employed on 
days 7 and 14. Thereafter on day 14, the animals were 
sacrificed and the biochemical estimations were 
performed. 
Group B (Sham control): Rats were subjected to the 
surgical procedure to expose the left sciatic nerve 
without any nerve ligation, they also received normal 
saline (2ml/kg) for 14 days. The behavioural tests were 
employed on days 7 and 14.  The animals were 
sacrificed on day 14 and the biochemical estimations 
were performed. 
Group C (ligated control): Rats were subjected to the 
surgical procedure to expose and ligate the left sciatic 
nerve. The behavioural tests and the biochemical 
analysis were carried out. Animals in this group also 
received normal saline (2ml/kg, i.p). 
Group D: Rats in this group received taurine 
(200mg/kg, i.p) alone for two weeks. Behavioural tests 
and biochemical analysis were also carried out as 
described for previous groups. 
Group E: Rats in this group received caffeine 
(15mg/kg, i.p) alone for two weeks. Behavioural tests 
and biochemical analysis were also carried out as 
described for other groups. 
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Group F: Rats were subjected to sciatic nerve ligation 
and treated with taurine (100mg/kg, i.p) + caffeine 
(7.5mg/kg, i.p) for two weeks. The behavioural tests 
and the biochemical analysis were also done. 
Group G: Rats were subjected to sciatic nerve ligation 
and treated with taurine (200mg/kg, i.p) + caffeine 
(15mg/kg, i.p) for two weeks. The behavioural tests and 
the biochemical analysis were also done. 
Group H-L: Same as for group F but animals were pre-
treated with propranolol (30mg/kg, i.p), 
Hexamethonium (10mg/kg, i.p), atropine (2mg/kg, i.p) 
and prazozin (5mg/kg, i.p) respectively. 
 
Induction of neuropathic pain 
 Neuropathic pain was induced through chronic 
constriction injury in line with the modified method of 
Bennette and Xie, (1998). In brief, each rat was deeply 
anesthetized with 50mg/kg ketamine and the skin of the 
lateral surface of the left thigh was incised and a cut 
was made directly through the biceps femoris muscle to 
expose the sciatic nerve Once exposed, the sciatic nerve 
was tightly ligated with silk 4-0 thread at two sites with 
about 1mm gap (Kumar et al., 2010)
. 
The silk suture 
was used instead of chromic gut suture as it has been 
documented that the chromic gut suture initiates 
inflammatory reactions in the sciatic nerve. Extra care 
was taken to avoid interruption of epineural blood flow 
while tying the ligature. In Sham operated animals, the 
same surgical procedure was also followed; the 
connective tissues were freed and ligatures were not 
applied. After performing the ligation, muscular and 
skin layer was immediately sutured with thread and 
topical antibiotic was applied. Nociceptive threshold 
was assessed at weekly intervals on days 7 and 14 after 
the surgery as suggested by Kumar et al. (2010). 
Tail Heat Hyperalgesia Test  
Thermal heat hyperalgesia was assessed by the tail 
immersion test as described by Necker and Hellon 
(1978).
 
Tail heat-hyperalgesia was noted with the 
immersion of terminal part of the tail (1cm) in water, 
maintained at a temperature of 52.5±0.50°C. The tail 
withdrawal latency (TWL) was recorded, as a response 
to heat thermal sensation, and a cut-off time of 15s was 
maintained.  
Tail Cold Hyperalgesia 
Thermal cold sensitivity was assessed by the tail 
immersion method as described by Necker and Hellon 
(1978).
 
Tail cold hyperalgesia was noted with the 
immersion of terminal part of the tail (1cm) in water 
maintained at a temperature of about 4°C. The tail 
withdrawal latency was recorded as a response of cold 
thermal sensation and a cut-off time of 15s was 
maintained. 
Paw heat-hyperalgesia (hot plate test) 
The thermal heat nociceptive threshold, as an index of 
thermal hyperalgesia, was assessed by using a hot plate, 
maintained at temperature of 52.5±1.0°C. The rat was 
placed on the hot plate and withdrawal latency, with 
respect to jumping off the hot plate, was recorded in 
seconds. The cut-off time of 15s was maintained. 
Assessment of oxidative stress in sciatic nerve 
Animals were euthanized with 50mg/kg ketamine on 
the 14
th
 day, sciatic nerve was immediately isolated and 
homogenized in 50mM phosphate buffer (pH 7.4). The 
homogenate was centrifuged at 1000rpm for 10min and 
the supernatant was used for estimation of tissue MDA 
concentration.  
 
Determination of MDA concentration 
The assay method of Gutteridge and Wilkins (1982) 
was adopted. Malondialdehyde, a product of lipid 
peroxidation, when heated with 2-thiobarbituric acid 
(TBA) under acid conditions forms a pink colored 
product which has a maximum absorbance of 532 nm. 
Two mililitre of 0.7% TBA and 1 ml of glacial acetic 
acid were added to 2 ml of serum. The mixture was 
thoroughly mixed and incubated in water bath at 80°C 
for 20 min. It was then allowed to cool and centrifuged 
at 400 rev/min for 10 min. Absorbance of the 
supernatant was read at 532 nm against a blank wherein 
homogenates was substituted with distilled water. The 
results were expressed as nanomoles MDA/ml. 
 
Statistical analysis 
The results were expressed in mean ± standard error of 
the mean (SEM). The results were analyzed using one 
way Analysis of variance (ANOVA), followed by 
DUNCAN post hoc test. P value <0.05 was considered 
to be statistically significant. 
  
RESULTS  
Effect of combined administration of taurine and 
caffeine on thermal  hyperalgesia and the effect of 
pre-treatment with autonomic receptor antagonists 
Chronic constriction injury to the sciatic nerve resulted 
in significant development of heat hyperalgesia 
compared to the ligated control group, assessed by 
employing the tail immersion tests and hot plate test. 
Combined systemic administration of taurine 
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Fig. 1: Effect of combined administration of taurine and caffeine on tail cold  hyperalgesia  and the effect of pre-treatment with 
autonomic receptor blockers.in rats. Bars with the same letterings are not significantly different from each other (for each day). 
NC- non ligated control, LC- ligated control, SC- sham operated control, TA- taurine alone, CA- caffeine alone, TCL- low 
dose of taurine and caffeine, TCH- high dose of taurine and caffeine, PTCL- propranolol+ low dose of taurine and caffeine, 
HTCL- hexamethonium+ low dose of taurine and caffeine, ATCL- Atropine+ low dose of taurine and caffeine, Prazosin + low 
dose of taurine and caffeine.Data were expressed as mean ± SEM and n=6. 
 
Fig. 2: Effect of combined administration of taurine and caffeine on tail heat hyperalgesia  and the effect of pre-treatment with 
autonomic receptor blockers.in rats. Bars with the same letterings are not significantly different from each other (for each day). 
NC- non ligated control, LC- ligated control, SC- sham operated control, TA- taurine alone, CA- caffeine alone, TCL- low 
dose of taurine and caffeine, TCH- high dose of taurine and caffeine, PTCL- propranolol+ low dose of taurine and caffeine, 
HTCL- hexamethonium+ low dose of taurine and caffeine, ATCL- Atropine+ low dose of taurine and caffeine, Prazosin + low 
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Table 1:Effect of combined administration of taurine and caffeine on MDA level in the sciatic nerve homogenate. 
GROUP                                                                           MDA level (nM/ml) 
Control       2.54±0.32a
 
Ligated control      4.42±0.61b 
Sham operated Control      2.40±0.18a
 
Taurine (200mg/kg, i.p)     3.00±0.23a
 
      Caffeine (15mg/kg, i.p)             4.53±0.52b
 
Taurine and caffeine (low dose)     3.13±0.65a
 
Taurine and caffeine (high dose)    2.95±0.12a 
 




Figure 3: Effect of combined administration of taurine and caffeine on paw heat  hyperalgesia  and the effect of pre-treatment 
with autonomic receptor blockers.in rats. Bars with the same letterings are not significantly different from each other (for each 
day). NC- non ligated control, LC- ligated control, SC- sham operated control, TA- taurine alone, CA- caffeine alone, TCL- 
low dose of taurine and caffeine, TCH- high dose of taurine and caffeine, PTCL- propranolol+ low dose of taurine and 
caffeine, HTCL- hexamethonium+ low dose of taurine and caffeine ,ATCL- Atropine+ low dose of taurine and caffeine, 
Prazosin + low dose of taurine and caffeine.Data were expressed as mean ± SEM and n=6. 
significantly attenuated the thermal hyperalgesia as 
shown by increase in tail and paw withdrawal latencies 
in treated groups  compared to the ligated control group 
(p<0.05)  (figures 1-3). Pre-treatment with atropine 
(2mg/kg, i.p) reversed the observed effect of combined 
administration of taurine and caffeine. Hexamethonium 
also abolished the antinociceptive effects of taurine and 
caffeine after two weeks in the hot plate test whereas 
the adrenergic antagonists did not abolish the effects of 
taurine and caffeine. 
Effect of combined administration of taurine and 
caffeine on oxidative stress damage marker (MDA 
level) 
CCI resulted into increase tissue MDA level in the 
sciatic nerve. However, treatment with taurine alone 
and in combination with caffeine (at the two doses) 
significantly reduced the MDA level compared to the 
ligated control group (P<0.05). Caffeine alone did not 
produce any significant effect on the tissue MDA level 
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compared with to the ligated control group (P>0.05) as 
shown in (table 1). 
 
Discussion 
In the present study, combined administration of 
taurine and caffeine attenuated thermal hyperalgesia 
induced by chronic constriction injury to the sciatic 
nerve. Sciatic nerve ligation has been reported to play a 
major role in the pathogenesis of neuropathic pain 
(Bennett and Xie, 1998). Neuropathic pain is usually 
triggered by lesions to the somatosensory nervous 
system that alter its structure and function that results in 
spontaneous pain and responses to noxious and 
innocuous stimuli are pathologically amplified 
(Costigan et al., 2009). Also it has been reported that 
no satisfactory therapeutic intervention is still available 
to treat sciatic nerve ligation-induced neuropathic pain. 
Thus, the present study was designed to explore the 
possible therapeutic strategy to prevent sciatic nerve 
ligation-induced neuropathic pain. 
Terada et al (2011) , reported that chronic constriction 
injury to the sciatic nerve resulted in mechanical 
allodynia, mechanical hyperalgesia, and thermal 
hyperalgesia. This observation  is supported by the fact 
that in the present study, rats subjected to sciatic nerve 
ligation showed significant (P<0.05) decrease in pain 
threshold compare to the groups treated with caffeine 
or taurine and in combination as shown in figures1-3.  
Caffeine, when administered alone inhibited thermal 
hyperalgesia in this study and this further confirmed the 
findings of Wu et al, (2006) which                                                                                          
stated that acute but not long term, caffeine intake 
reduced neuropathic pain state in nerve- injured rats. 
This could be due to the ability of caffeine to induce 
central cholinergic analgesia (Ghelardini et al., 1997). 
Treatment with taurine alone also significantly 
increased pain threshold which is in line with what has 
been reported by Terada et al (2011) and it was 
attributed to the ability of taurine to reduce spinal and 
supraspinal integrated pain responses. 
Caffeine is known to act as adjuvant analgesic and it 
enhanced the effect of taurine in this study which is in 
line with its action on headache pain (Zhang, 2001). 
Caffeine induced antinociception is attributed to block 
of adenosine A2A and A2B receptors and such action 
may also contribute to adjuvant analgesia. 
Pellicer et al. (2007) reported that taurine in the 
cingulate cortex interfered with the glycine receptor 
and induced antinociception. Taurine is known to bind 
with GABA and glycine receptors and both 
GABAergic and Glycinergic neurons in the dorsal horn 
of the spinal cord have emerged as the pivotal 
inhibitory modulators of spinal pain in inflammatory 
and neuropathic pain (Zeilhofer, 2005). Though, the 
present study does not investigate the role of GABA 
receptors in the attenuating effect of combined 
administration of taurine and caffeine on thermal 
hyperalgesia. 
Various autonomic receptor antagonists were employed 
in this study to explore the possible involvement of 
autonomic nervous system. The autonomic receptor 
antagonists employed include: atropine, 
hexamethonium, propranolol and prazosin. Atropine, a 
muscarinic receptor antagonist abolished the 
antihyperalgesic effect of combined administration of  
taurine and caffeine in the tail heat hyperalgesia and hot 
plate tests as shown in Tables 2 and 3 suggesting the 
involvement of muscarinic system/cholinergic system. 
Analgesia via activation of muscarinic receptors has 
been described and it is known to be centrally mediated 
(Pedigo et al., 1975). Though, the therapeutic use of 
direct muscarinic agonists clinically was never pursued, 
due to severe side effects. The nicotinc receptors could 
also be involved in the taurine-caffeine mediated 
antinociption as shown by its inhibitory effects after 
two weeks of ligation. The adrenergic mechanism 
seems not be involved in the anti nociceptive effects of 
the two substances but they may serve as adjuvants to 
them. 
Moreover, sciatic nerve ligation has been reported to 
cause imbalance in reactive oxygen species (ROS) and 
antioxidant enzymes (Senoglu et al., 2009). This is 
strongly supported by the fact that in the present study, 
sciatic nerve ligated rats showed high degree of 
oxidative stress which is expressed by high levels of 
lipid peroxidation i.e. increase in MDA level. Previous 
report by Xu et al.(2007) showed that oxidative stress 
occurs due to activation of  p38MAPK pathway . In 
turn p38MAPK  have been shown to increase the 
production of various inflammatory mediators such as 
TNF-α, ILs, COX-2 which are important mediators for 
the progression of neuropathic pain.( Raghavendra et 
al., 2003) . However, we did not investigate the effects 
of caffeine and taurine on inflammatory mediators. 
Combined administration of taurine and caffeine in the 
present study attenuated the ligation-induced increase 
in the level of  lipid peroxidation within the sciatic 
nerve as shown in table 1. Taurine is found particularly 
in high concentrations in tissues exposed to elevated 
levels of oxidants, suggesting its role in the attenuation 
of oxidative stress (Green et al., 1991). Thus, it is likely 
that taurine and caffeine when administered together 




In conclusion, the present study showed that combined 
administration of taurine and caffeine inhibited thermal 
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hyperalgesia associated with sciatic nerve ligation 
which involves activation of muscarinic but not 
nicotinic receptors of the cholinergic system.  There is 
also attenuation of oxidative stress and consequently an 
improvement of the normal function of sciatic nerve. 
Therefore, this study has shown that combination of 
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